|
|
|
MIRA INFORM REPORT
|
Report No. : |
504437 |
|
Report Date : |
20.04.2018 |
IDENTIFICATION DETAILS
|
Name : |
CHENNAI RR MEDICOS PRIVATE LIMITED |
|
|
|
|
Registered
Office : |
1st Floor, Shop No. 1, Old No. 71, New No. 137, Choolai
High Road, Chennai-600112, Tamilnadu |
|
Tel. No.: |
91-44-42804570/ 42862220 |
|
|
|
|
Country : |
India |
|
|
|
|
Financials (as
on) : |
31.03.2017 [Proprietorship Firm] |
|
|
|
|
Date of Incorporation
: |
07.07.2017 |
|
|
|
|
Com. Reg. No.: |
18-117446 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
INR 5.102 Million [Proprietorship Firm] |
|
|
|
|
CIN No.: [Company Identification
No.] |
U51909TN2017PTC117446 |
|
|
|
|
IEC No.: [Import-Export Code No.] |
Not Divulged |
|
|
|
|
TIN No.: |
Not Divulged |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
Not Available |
|
|
|
|
GSTN : [Goods & Service Tax
Registration No.] |
33AAHCC0867F1ZV |
|
|
|
|
PAN No.: [Permanent Account No.] |
AAHCC0867F |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Distributor of Pharmaceutical Products. [Registered Activity and also
Confirmed by Management] |
|
|
|
|
No. of Employees
: |
10 (Approximately) |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A |
|
Credit Rating |
Explanation |
Rating Comments |
|
A |
Acceptable Risk |
Business dealings permissible with moderate
risk of default |
|
Maximum Credit Limit : |
USD 14500 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject was originally established as proprietorship concern in the year 1994 and later on 7th July 2017 it got converted into private limited company with the name of “Chennai RR Medicos Private Limited”. As per the available financials of March 2017, the concern has achieved decent growth in its revenue as compared to its previous year but has reported thin profit margin during the year. Rating takes into consideration, the satisfactory financial risk profile marked by adequate capital base and fair liquidity position. Rating continues to derive strength from its long and established track record of its business operation and considerable experience of its promoters. Further the subject’s customer “Suran Enterprise” claimed that they are satisfied with their product quality and delivery behaviour. Even its supplier “Suran Enterprise” and “Rishab Distributor” gave positive feedback and they are satisfied with subject’s payment behaviour and market goodwill. As per the provisional financial record of March 2018, the subject has achieved revenue of 270.000 million. However, these rating strengths get partially offset by newly established company in highly competitive pharmaceutical industry. Payment seems to be usually correct. In view of aforesaid, the company can be considered for business dealing usual trade terms and conditions. NOTE 1: The financials available for the year 2017 are of proprietorship concern i.e. “RR Pharma” and the provision financial figure are of private limited company i.e. “Chennai RR Medicos Private Limited”. NOTE 2: Site visit will be sent in due course. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EXTERNAL AGENCY RATING
NOT AVAILABLE
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2016.
BIFR (Board for Industrial & Financial Reconstruction) LISTING STATUS
Subject’s name is not listed as a Sick Unit in
the publicly available BIFR (Board for Industrial & Financial
Reconstruction) list as of 20.04.2018.
IBBI (Insolvency and Bankruptcy Board of India) LISTING STATUS
Subject’s name is not listed in the publicly
available IBBI (Insolvency and Bankruptcy Board of India) list as of report
date.
INFORMATION PARTED BY
|
Name : |
Mr. Rajmal Jain |
|
Designation : |
Director |
|
Contact No.: |
91-9381005217 |
|
Date : |
19.04.2018 |
LOCATIONS
|
Registered Office : |
1st Floor, Shop No. 1, Old No. 71, New No. 137, Choolai
High Road, Chennai-600112, Tamilnadu, India |
|
Tel. No.: |
91-44-42804570/ 42862220 |
|
Mobile No.: |
91-9381005217/ 7401111187 [Mr. Rajmal Jain] |
|
Fax No.: |
Not Available |
|
E-Mail : |
|
|
Location : |
Rented |
DIRECTORS
AS ON: 31.03.2017
|
Name : |
Mr. Rajmal Jain |
|
Designation : |
Director |
|
Address : |
21/1, Jaswant Nagar, Phase – 1, Mogappair West,
Chennai-600037, Tamilnadu, India |
|
Date of Birth/Age : |
11.07.1971 |
|
Qualification : |
D. Form |
|
Experience : |
25 Years |
|
Date of Appointment : |
07.07.2017 |
|
DIN No.: |
07786774 |
|
|
|
|
Name : |
Mrs. Rekha |
|
Designation : |
Director |
|
Address : |
21/1, Phase 1, Jaswanth Nagar, Mogappair West, Tiruvallur,
Chennai-600037, Tamilnadu, India |
|
Date of Birth/Age : |
24.06.1975 |
|
Qualification : |
S.S.LC |
|
Experience : |
15 Years |
|
Date of Appointment : |
19.02.2018 |
|
PAN No.: |
ALZPR9298R |
|
DIN No.: |
08069966 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
AS ON: 06.07.2017
|
Names of Shareholders |
No. of Shares |
Percentage of Holding |
|
Deepak Agarwal |
25000 |
50.00 |
|
Rajmal Jain |
25000 |
50.00 |
|
|
|
|
|
Total |
50000 |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Distributor of Pharmaceutical Products. [Registered Activity and also
Confirmed by Management] |
|
|
|
|
Products/ Services : |
Pharmaceutical Products |
|
|
|
|
Brand Names : |
Not Available |
|
|
|
|
Agencies Held : |
· Sun Pharma · GlaxoSmithKline Pharmaceuticals · Lupin · Alembic |
|
|
|
|
Exports : |
|
|
Products : |
Not Available |
|
Countries : |
Not Available |
|
|
|
|
Imports : |
|
|
Products : |
Not Available |
|
Countries : |
Not Available |
|
|
|
|
Terms : |
|
|
Selling : |
Credit [7 Days] |
|
|
|
|
Purchasing : |
Credit [7 Days] |
PRODUCTION STATUS: (NOT AVAILABLE)
GENERAL INFORMATION
|
Suppliers : |
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Customers : |
Wholesaler and Retailers
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
No. of Employees : |
10 (Approximately) |
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Bankers : |
|
||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||
|
Facilities : |
[PROPRIETORSHIP FIRM]
|
|
|
|
|
Auditors : |
|
|
Name : |
L. Ramesh and Associates Chartered Accountants |
|
Address : |
No 7, Peddunaiken Street, Chennai-79, Tamilnadu, India |
|
Tel. No.: |
91-8667453821 |
|
E-Mail : |
|
|
|
|
|
Memberships : |
Not Available |
|
|
|
|
Collaborators : |
Not Available |
|
|
|
|
Sister Concern : |
· Himalayan Agencies Address: 219, MTH Road,
Ambattur, Chennai-53, Tamilnadu, India Line of
Business: Pharma Wholesale Business |
CAPITAL STRUCTURE
CHENNAI RR MEDICOS PRIVATE LIMITED
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
100000 |
Equity Shares |
INR 10/- each |
INR 1.000 Million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
50000 |
Equity Shares |
INR 10/- each |
INR 0.500
Million |
|
|
|
|
|
R.R.
PHARMA [PROPRIETORSHIP FIRM]
CAPITAL ACCOUNT AS ON
31.03.2017
|
PARTICULARS |
INR
IN MILLION |
|
Opening Balance |
3.631 |
|
Add: Net Profit |
1.109 |
|
Gas Subsidy Received |
0.002 |
|
Interest recd. on savings A/c |
0.000 |
|
Gift From Friends and Relatives |
1.096 |
|
|
----------- |
|
Total |
5.838 |
|
|
|
|
Less: Drawings |
0.280 |
|
Credit Cards |
0.130 |
|
Exide Life Insurance |
0.033 |
|
Bajaj Allaince Life Insurance |
0.015 |
|
Advance Income Tax |
0.150 |
|
Income Tax Paid |
0.027 |
|
LIC Premium Paid |
0.101 |
|
|
----------- |
|
Total |
0.736 |
|
|
----------- |
|
Total |
5.102 |
FINANCIAL DATA
[all figures are
in INR Million]
NEW BUSINESS
|
PARTICULARS |
|
|
31.03.2018 [Provisional] |
|
Sales Turnover (Approximately) |
|
|
270.000 |
|
|
|
|
|
Expected Sales (2018-2019): INR 300.000 Million
The above information has been parted by Mr. Rajmal Jain [Director]
R.R. PHARMA [PROPRIETORSHIP FIRM]
ABRIDGED
BALANCE SHEET
|
SOURCES OF FUNDS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Capital Account |
5.102 |
3.631 |
3.479 |
|
|
2] Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
5.102 |
3.631 |
3.479 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.657 |
1.432 |
2.231 |
|
|
2] Unsecured Loans |
2.217 |
0.000 |
2.222 |
|
|
TOTAL BORROWING |
2.874 |
1.432 |
4.453 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
7.976 |
5.063 |
7.932 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
4.683 |
4.970 |
4.543 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.020 |
0.020 |
0.020 |
|
|
DEFERREX TAX ASSETS |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
7.390
|
6.988
|
5.816
|
|
|
Sundry Debtors |
6.307
|
8.703
|
7.250
|
|
|
Cash & Bank Balances |
0.105
|
0.291
|
0.060
|
|
|
Other Current Assets |
0.155
|
0.164
|
0.062
|
|
|
Loans & Advances |
4.686
|
0.500
|
0.502
|
|
Total
Current Assets |
18.643
|
16.646
|
13.690
|
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
15.310
|
12.175
|
10.311
|
|
|
Other Current Liabilities |
0.000
|
4.312
|
0.010
|
|
|
Provisions |
0.060
|
0.086
|
0.000
|
|
Total
Current Liabilities |
15.370
|
16.573
|
10.321
|
|
|
Net Current Assets |
3.273
|
0.073
|
3.369
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
7.976 |
5.063 |
7.932 |
|
PROFIT
& LOSS ACCOUNT
|
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales |
259.980 |
216.671 |
205.788 |
|
|
|
Other Income |
0.000 |
0.000 |
0.011 |
|
|
|
TOTAL |
259.980 |
216.671 |
205.799 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Goods Sold |
254.741 |
203.393 |
196.517 |
|
|
|
Audit Fees |
0.000 |
0.000 |
0.010 |
|
|
|
Bank OD Interest |
0.079 |
0.142 |
0.147 |
|
|
|
Battery Maintenance |
0.006 |
0.005 |
0.003 |
|
|
|
Bonus |
0.000 |
0.743 |
0.816 |
|
|
|
Business Promotion |
0.746 |
0.821 |
0.757 |
|
|
|
Camera Maintenance |
0.011 |
0.012 |
0.012 |
|
|
|
Car Maintenance |
0.096 |
0.089 |
0.085 |
|
|
|
Cellphone Charges |
0.035 |
0.050 |
0.056 |
|
|
|
Computer Maintenance |
0.062 |
0.055 |
0.045 |
|
|
|
Conveyance |
0.092 |
0.348 |
0.310 |
|
|
|
Donation (Save the Children) |
0.000 |
0.169 |
0.000 |
|
|
|
Courier Charges |
0.034 |
0.031 |
0.025 |
|
|
|
Electricity Charges |
0.128 |
0.097 |
0.104 |
|
|
|
House Rent Allowance |
0.096 |
0.096 |
0.096 |
|
|
|
Incentives |
0.000 |
0.422 |
0.000 |
|
|
|
Insurance |
0.016 |
0.017 |
0.000 |
|
|
|
Motorbike Maintenance |
0.028 |
0.024 |
0.029 |
|
|
|
Pooja Expenses |
0.036 |
0.032 |
0.048 |
|
|
|
Printing and Stationery |
0.062 |
0.059 |
0.073 |
|
|
|
Processing Charges |
0.004 |
0.019 |
0.047 |
|
|
|
Rent paid |
0.180 |
0.111 |
0.180 |
|
|
|
Rent paid (Old) |
0.000 |
0.150 |
0.000 |
|
|
|
Salary Paid |
1.030 |
6.215 |
4.575 |
|
|
|
Shop Expenses |
0.055 |
0.296 |
0.257 |
|
|
|
Staff Welfare Expenses |
0.000 |
0.312 |
0.000 |
|
|
|
Stock Insurance |
0.000 |
0.000 |
0.014 |
|
|
|
Subscription |
0.021 |
0.009 |
0.015 |
|
|
|
Amenities |
0.001 |
0.000 |
0.000 |
|
|
|
Telephone Charges |
0.000 |
0.033 |
0.029 |
|
|
|
Vat Interest Paid |
0.000 |
0.000 |
0.001 |
|
|
|
Weekly Batta |
0.000 |
0.618 |
0.000 |
|
|
|
TOTAL |
257.559 |
214.368 |
204.251 |
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE INTEREST AND DEPRECIATION AND AMORTISATION |
2.421 |
2.303 |
1.548 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES |
0.849 |
0.913 |
0.238 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE DEPRECIATION AND AMORTISATION |
1.572 |
1.390 |
1.310 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION |
0.288 |
0.284 |
0.128 |
|
|
|
|
|
|
|
|
|
|
NET PROFIT/
(LOSS) |
1.284 |
1.106 |
1.182 |
|
CURRENT MATURITIES OF LONG TERM DEBT DETAILS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Maturities of Long term debt |
NA |
NA |
NA |
|
|
|
|
|
|
Cash generated from operations |
NA |
NA |
NA |
|
|
|
|
|
|
Net Cash flow from (used in) Operations |
NA |
NA |
NA |
KEY
RATIOS
EFFICIENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Average Collection Days (Sundry
Debtors / Income * 365 Days) |
8.85 |
14.66 |
12.86 |
|
|
|
|
|
|
Account Receivables Turnover (Income / Sundry Debtors) |
41.22 |
24.90 |
28.38 |
|
|
|
|
|
|
Average Payment Days (Sundry Creditors / Purchases * 365 Days) |
21.94 |
21.85 |
19.15 |
|
|
|
|
|
|
Inventory Turnover (Operating Income / Inventories) |
0.33 |
0.33 |
0.27 |
|
|
|
|
|
|
Asset Turnover (Operating Income / Net Fixed Assets) |
0.52 |
0.46 |
0.34 |
LEVERAGE RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Debt Ratio ((Borrowing
+ Current Liabilities) / Total Assets) |
0.78 |
0.83 |
0.81 |
|
|
|
|
|
|
Debt Equity Ratio (Total Liability / Networth) |
0.56 |
0.39 |
1.28 |
|
|
|
|
|
|
Current Liabilities to Networth (Current Liabilities / Net Worth) |
3.45 |
4.56 |
3.61 |
|
|
|
|
|
|
Fixed Assets to Networth (Net Fixed Assets / Networth) |
0.92 |
1.37 |
1.31 |
|
|
|
|
|
|
Interest Coverage Ratio (PBIT / Financial Charges) |
2.85 |
2.52 |
6.50 |
PROFITABILITY RATIOS
|
PARTICULARS |
|
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Net Profit Margin ((PAT / Sales) * 100) |
% |
0.49 |
0.51 |
0.57 |
|
|
|
|
|
|
|
Return on Total Assets ((PAT / Total Assets) * 100) |
% |
5.50 |
5.11 |
6.48 |
|
|
|
|
|
|
|
Return on Investment (ROI) ((PAT / Networth) * 100) |
% |
25.17 |
30.46 |
33.98 |
SOLVENCY RATIOS
|
PARTICULARS |
31.03.2017 |
31.03.2016 |
31.03.2015 |
|
Current Ratio (Current
Assets / Current Liabilities) |
1.06 |
1.00 |
1.09 |
|
|
|
|
|
|
Quick Ratio ((Current Assets – Inventories) / Current
Liabilities) |
0.64 |
0.58 |
0.63 |
|
|
|
|
|
|
G-Score Ratio Financial (Networth / Total Assets) |
0.22 |
0.17 |
0.19 |
|
|
|
|
|
|
G-Score Ratio Debt (Debts / Equity Capital) |
0.56 |
0.39 |
1.28 |
|
|
|
|
|
|
G-Score Ratio Liquidity (Total Current Assets / Total Current Liabilities) |
1.06 |
1.00 |
1.09 |
Total
Liability = Short-term Debt + Long-term Debt + Current Maturities of Long-term
debts
FINANCIAL ANALYSIS
[all figures are
in INR Million]
R.R. PHARMA [PROPRIETORSHIP FIRM]
DEBT EQUITY RATIO
|
Particulars |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Capital Account |
3.479 |
3.631 |
5.102 |
|
Reserves & Surplus |
0.000 |
0.000 |
0.000 |
|
Net
worth |
3.479 |
3.631 |
5.102 |
|
Secured Loans |
2.231 |
1.432 |
0.657 |
|
Unsecured Loans |
2.222 |
0.000 |
2.217 |
|
Total
borrowings |
4.453 |
1.432 |
2.874 |
|
Debt/Equity
ratio |
1.280 |
0.394 |
0.563 |
YEAR-ON-YEAR GROWTH
|
Year
on Year Growth |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
205.788 |
216.671 |
259.980 |
|
|
|
5.288 |
19.988 |
NET PROFIT MARGIN
|
Net
Profit Margin |
31.03.2015 |
31.03.2016 |
31.03.2017 |
|
|
INR
In Million |
INR
In Million |
INR
In Million |
|
Sales |
205.788 |
216.671 |
259.980 |
|
Profit |
1.182 |
1.106 |
1.284 |
|
|
0.57% |
0.51% |
0.49% |
LOCAL AGENCY FURTHER INFORMATION
|
Sr. No. |
Check list by
info agents |
Available in
Report (Yes/No) |
|
1 |
Year of establishment |
Yes |
|
2 |
Constitution of the entity -Incorporation
details |
Yes |
|
3 |
Locality of the entity |
Yes |
|
4 |
Premises details |
No |
|
5 |
Buyer visit details |
-- |
|
6 |
Contact numbers |
Yes |
|
7 |
Name of the person contacted |
Yes |
|
8 |
Designation of contact person |
Yes |
|
9 |
Promoter’s background |
Yes |
|
10 |
Date of Birth of Proprietor / Partners /
Directors |
Yes |
|
11 |
Pan Card No. of Proprietor / Partners |
Yes |
|
12 |
Voter Id Card No. of Proprietor / Partners |
No |
|
13 |
Type of business |
Yes |
|
14 |
Line of Business |
Yes |
|
15 |
Export/import details (if applicable) |
No |
|
16 |
No. of employees |
Yes |
|
17 |
Details of sister concerns |
Yes |
|
18 |
Major suppliers |
Yes |
|
19 |
Major customers |
Yes |
|
20 |
Banking Details |
Yes |
|
21 |
Banking facility details |
Yes |
|
22 |
Conduct of the banking account |
Yes |
|
23 |
Financials, if provided |
Yes |
|
24 |
Capital in the business |
Yes |
|
25 |
Last accounts filed at ROC, if applicable |
Yes |
|
26 |
Turnover of firm for last four years |
Yes |
|
27 |
Reasons for variation <> 20% |
-- |
|
28 |
Estimation for coming financial year |
Yes |
|
29 |
Profitability for last three years |
Yes |
|
30 |
Major shareholders, if available |
Yes |
|
31 |
External Agency Rating, if available |
No |
|
32 |
Litigations that the firm/promoter
involved in |
-- |
|
33 |
Market information |
-- |
|
34 |
Payments terms |
Yes |
|
35 |
Negative Reporting by Auditors in the
Annual Report |
No |
INDEX OF CHARGES: NO
CHARGES EXISTS FOR COMPANY
UNSECURED LOANS
[PROPRIETORSHIP FIRM]
|
PARTICULARS |
31.03.2017 (INR
In Million) |
31.03.2016 (INR
In Million) |
|
Kausalyabai |
1.100 |
0.000 |
|
Religare Finvest Limited Loan |
0.137 |
0.000 |
|
Advance received from Retail customers |
0.980 |
0.000 |
|
|
|
|
|
Total |
2.217 |
0.000 |
FIXED ASSETS:
[PROPRIETORSHIP FIRM]
Tangible Assets
·
Furniture
·
Electrical Fittings
· Plant & Machinery,
· Cars
·
10-Computer
·
Software
·
Books (Profession)
·
Gas Cylinders
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
INR |
|
US Dollar |
1 |
INR 65.78 |
|
UK Pound |
1 |
INR 93.42 |
|
Euro |
1 |
INR 81.39 |
INFORMATION DETAILS
|
Information
Gathered by : |
SAV |
|
|
|
|
Analysis Done by
: |
NIS |
|
|
|
|
Report Prepared
by : |
IND |
SCORE FACTORS
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.